BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18237604)

  • 1. Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century.
    Bhattacharyya S; Toumpanakis C; Caplin ME; Davar J
    Am J Cardiol; 2008 Feb; 101(3):378-81. PubMed ID: 18237604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of patent foramen ovale in carcinoid heart disease.
    Mansencal N; Mitry E; Forissier JF; Martin F; Redheuil A; Lepère C; Farcot JC; Joseph T; Lacombe P; Rougier P; Dubourg O
    Am Heart J; 2006 May; 151(5):1129.e1-6. PubMed ID: 16644350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease.
    Mansencal N; Mitry E; Pillière R; Lepère C; Gérardin B; Petit J; Gandjbakhch I; Rougier P; Dubourg O
    Am J Cardiol; 2008 Apr; 101(7):1035-8. PubMed ID: 18359327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent foramen ovale in carcinoid heart disease.
    Mansencal N; Touhami I; Mitry E; Rougier P; Dubourg O
    Int J Cardiol; 2010 Jul; 142(2):e29-31. PubMed ID: 19157592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI.
    Bhattacharyya S; Toumpanakis C; Burke M; Taylor AM; Caplin ME; Davar J
    Circ Cardiovasc Imaging; 2010 Jan; 3(1):103-11. PubMed ID: 19920029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.
    Pellikka PA; Tajik AJ; Khandheria BK; Seward JB; Callahan JA; Pitot HC; Kvols LK
    Circulation; 1993 Apr; 87(4):1188-96. PubMed ID: 7681733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urgent transcatheter closure of patent foramen ovale followed by elective right-sided valve surgery for decompensated carcinoid heart disease.
    Hayashi Y; McGaw DJ; Goldstein J
    Heart Lung Circ; 2008 Jun; 17(3):259-61. PubMed ID: 17416551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoid heart disease with right to left shunt across a patent foramen ovale: a case report and review of literature.
    Chowdhury MA; Taleb M; Kakroo MA; Tinkel J
    Echocardiography; 2015 Jan; 32(1):165-9. PubMed ID: 24976489
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease.
    Zuetenhorst JM; Korse CM; Bonfrer JM; Bakker RH; Taal BG
    Br J Cancer; 2004 Jun; 90(11):2073-9. PubMed ID: 15150565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of prognostic value of tissue Doppler imaging in carcinoid heart disease versus the value in patients with the carcinoid syndrome but without carcinoid heart disease.
    Mansencal N; McKenna WJ; Mitry E; Beauchet A; Pellerin D; Rougier P; Dubourg O
    Am J Cardiol; 2010 Feb; 105(4):527-31. PubMed ID: 20152249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoid heart disease with severe hypoxia due to interatrial shunt through patent foramen ovale.
    Boglioli LR; Gardiner J; Gerstenblith G; Taff ML; Cameron DE
    Tex Heart Inst J; 1997; 24(2):125-8. PubMed ID: 9205988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoid heart disease revealed by cyanosis with both right and left valvular involvement: a case report.
    Khay K; Arous S; Bentaoune T; Drighil A; Habbal R
    J Med Case Rep; 2018 Jan; 12(1):23. PubMed ID: 29386066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular abnormalities in patients with a carcinoid syndrome.
    Meijer WC; van Veldhuisen DJ; Kema IP; Van den Berg MP; Boomsma F; Willemse PH; De Vries EG
    Neth J Med; 2002 Mar; 60(1):10-6. PubMed ID: 12074037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progressive dyspnoea in two patients with carcinoid syndrome].
    Nölting S; Nicolaus M; Behr J; Baumgartner R; Mete H; Boekstegers P; Herrmann K; Theisen D; Lehrke M; Göke B; Schirra J; Auernhammer CJ
    Internist (Berl); 2010 Nov; 51(11):1439-45. PubMed ID: 20628718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and evolution of carcinoid syndrome in the heart.
    Moyssakis IE; Rallidis LS; Guida GF; Nihoyannopoulos PI
    J Heart Valve Dis; 1997 Nov; 6(6):625-30. PubMed ID: 9427132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tricuspid insufficiency disclosing carcinoid syndrome].
    Monségu J; Algayres JP; Ciribilli JM; Bussière JL; Duriez P; Gaillard JF; Daly JP
    Rev Med Interne; 1994; 15(9):593-6. PubMed ID: 7984839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI and CT revealing carcinoid heart disease.
    Mollet NR; Dymarkowski S; Bogaert J
    Eur Radiol; 2003 Dec; 13 Suppl 6():L14-8. PubMed ID: 16440219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of patients with carcinoid heart disease after valvular surgery.
    Manoly I; McAnelly SL; Sriskandarajah S; McLaughlin KE
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):302-5. PubMed ID: 24812331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the optimal echocardiographic scoring system to quantify carcinoid heart disease.
    Dobson R; Cuthbertson DJ; Jones J; Valle JW; Keevil B; Chadwick C; Poston GP; Burgess MI
    Neuroendocrinology; 2014; 99(2):85-93. PubMed ID: 24603343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiographic follow-up of treated patients with carcinoid syndrome.
    Mansencal N; Mitry E; Bachet JB; Rougier P; Dubourg O
    Am J Cardiol; 2010 Jun; 105(11):1588-91. PubMed ID: 20494667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.